DiaMedica Therapeutics (DMAC) Other Non-Current Assets (2017 - 2024)

DiaMedica Therapeutics' (DMAC) quarterly Other Non-Current Assets came in at $1.3 million in Q4 2024, little changed quarter-over-quarter from $1.3 million in Q3 2024.

DiaMedica Therapeutics (DMAC) Other Non-Current Assets (2017 - 2024) Analysis & Trends

DiaMedica Therapeutics' Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $1.3 million for Q4 2024.

  • On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $1.3 million in Q4 2024; TTM through Dec 2024 was $1.3 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.3 million, changed N/A from the prior year.
  • Other Non-Current Assets held at $1.3 million in Q4 2024 per DMAC's latest filing, from $1.3 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.3 million in Q1 2024 and bottomed at $1.3 million in Q1 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 1.02 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 60,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 104.24 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 289.41 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 14.48 Mn
10 DiaMedica Therapeutics 364.72 Mn 364.72 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 1.31 Mn
Sep 30, 2024 1.31 Mn
Jun 30, 2024 1.31 Mn
Mar 31, 2024 1.31 Mn
Jun 30, 2019 271,000.00
Mar 31, 2019 271,000.00
Dec 31, 2018 271,000.00
Dec 31, 2017 271,000.00